Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery

Abstract Human carbonic anhydrase XII (hCA XII) isozyme is of high therapeutic value as a pharmacological target and biomarker for different types of cancer. The hCA XII is one of the crucial effectors that regulates extracellular and intracellular pH and affects cancer cell proliferation, invasion,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mohammad M. Al-Sanea, Garri Chilingaryan, Narek Abelyan, Grigor Arakelov, Harutyun Sahakyan, Vahram G. Arakelov, Karen Nazaryan, Shaimaa Hussein, Gharam M. Alazmi, Haifa E. Alsharari, Waad M. Al-faraj, Faten S. Alruwaili, Nouf Q. Albilasi, Tahani S. Alsharari, Abdulaziz A. S. Alsaleh, Turki M. Alazmi, Atiah H. Almalki, Nasser H. Alotaibi, Mohamed A. Abdelgawad
Format:	article
Language:	EN
Published:	Nature Portfolio 2021
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/2c1d4ac6a4d343049a08b2c705fe9f50
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery

Similar Items